Selected Documents and Publications

• Medscape Blogs:
  • “It’s Time to Start Talking About Back-to-School Vaccinations,” July 19, 2022
  • “With US Gun Violence, Silence = Death, so Where Is the Outrage?,” June 08, 2022
  • “Testing and Treating Can Help Normalize COVID and Daily Life,” April 08, 2022
  • “Dos and Don’ts for Post-pandemic Masks,” March 22, 2022
  • “Clinical Transformation Is the Foundation for Care Improvement,” March 08, 2022
  • “Prices of Prescription Drugs Are Complex and Opaque,” January 28, 2022
  • “Talk With — Not To — Your Patients About COVID Vaccines,” January 12, 2022

• HealthyWomen Blogs:
  • “Lost Your Job? Here’s How to Find New Health Insurance,” March 31, 2020
  • “What Are ‘Surprise Medical Bills’? Six Ways to Address Unexpected Health-Care Costs,” March 11, 2020
  • “For Better Women’s Health, Expand the ACA, Not Medicare,” February 4, 2020
  • “9 Reasons to Get the Flu Vaccine,” December 4, 2019
  • “Seven Key Things to Know When Choosing Health Insurance During Open Enrollment,” October 6, 2019
  • “Vaping is Bad for Everyone, and It’s Especially Unhealthy for Children,” September 16, 2019
  • “Importation of Prescription Drugs—Soothing Salve or Irritating Lotion?” August 16, 2019
  • “CBD Here, There, Everywhere! CBD and Women’s Health,” July 15, 2019
  • “Opioids: An Evolving Health Crisis for Women,” July 10, 2019
  • “New Prescription Drug Proposal Will Help Women and Their Families,” April 16, 2019
  • “Medicare-for-All and Women’s Health,” April 8, 2019
  • “HealthyWomen Opposes Proposed Changes to Title IX’s Rules for Sexual Harassment and Assaults Involving Students,” (with HealthyWomen’s CEO Beth Battaglino, RN), March 12, 2019
  • “What You Need to Know for Open Enrollment Health Insurance Season,” October 29, 2018

• HealthyWomen letter (with CEO Beth Battaligno, RN), opposing HHS’ proposed changes concerning “Nondiscrimination in Health and Health Education Programs or Activities,” in Section 1557 of the ACA,” August 13, 2019

• “Women’s Health Facts and Perspectives,” Prepared for HealthyWomen, May 2019

• HealthyWomen letter to Department of Education (with CEO Beth Battaligno, RN), opposing proposed changes to Title IX for handling sexual harassment and assault events involving students, January 29, 2019

• Quoted in O Magazine article, “6 Things Women Should Demand From Healthcare Coverage,” June 13, 2017

• “Understanding Evidence about the Value of Medical Technologies,” Prepared for AdvaMed, May 2017

• “Tele-ICU And Clinical Quality,” Letter to the Editor, Health Affairs, November/December 2009, pp 1858-59

• “Electronic Medical Records: Setting the Records Straight,” Medical Times of the Middle East, June 2008

• Tele-ICUs: Interim Findings about Remote Monitoring and Management of Patients in Intensive Care Units: A FAST Initiative Technology Analysis, Discussion Draft for the New England Healthcare Institute, Prepared by Michael D. Miller, MD & Sheila Fifer, PhD – August 2006

• A White Paper Analysis of Marcia Angell’s February 12, 2007 Boston Globe Column, “High cost of me-too drugs”

• “Implications of pharmaceutical ballot propositions for veterans,” California Legionnaire, Sept/Oct 2005.

• “Life sciences companies can expect lively drug pricing debate in 2005,” Mass High Tech, Life Science Strategies Supplement, January 17, 2005 [link to Mass High Tech]

• VA Pharmaceutical Price Controls, Rationing, and Medicare,” January 2005 (Summary)

• “Drug Pricing Principles” in “The Entrepreneur’s Guide to a Biotech Startup,” 4th Edition, May 2004

• “New Advancements in Treating Osteoporosis” July 2003 (Unpublished Article)

• “The Pharmaceutical Industry’s Contribution to Economic Development and Prosperity in Pennsylvania,” Testimony Before House Majority Policy Committee Hearing, Sub-Committee on Prescription Drugs (PACE/PACENET), Folsom, PA, July 16, 2002

• Testimony Before the United States Senate’s Committee on Veterans’ Affairs, Hearing on Prescription Drug Issues in the Department of Veterans Affairs, July 24, 2001

• “Working Together on Common Concerns and Complex Solutions,” PhRMA’s “Patient Matters” Newsletter, Fall 2000

• Congressional Testimony in support of funding for NHGRI and NIH on behalf of The Genome Action Coalition (with Vicky Wittemore, Ph.D. National Tuberous Sclerosis Association), House Appropriations Labor-HHS Subcommittee, 13 April, 1999

• Congressional Testimony in support of funding for the NIH on behalf of FDA-NIH Council, House Appropriations Labor-HHS Subcommittee, 28 January, 1998

• The Value of Prescription Drugs and Pharmaceutical Research, Pfizer Briefing Book, Editor, 1995, 1996, 1997 Editions

• Miller, M.D., Remillard, S., “Preparing for Managed Care and Capitation,” in, Alliances:  Strategies for Building Integrated Delivery Systems, Aspen Publications, 1995

• Patent # 4,857,061: “Single-Flow Valve-Hypodermic Needle Combination,” 15 August, 1989

• Puzas, J.E., Miller, M.D., Rosier, R.N., “Pathological Bone Formation,” Clinical Orthopaedics and Related Research 245, pp 269-281, 1989

• Miller, M.D., Hausman, M., Jokl, P., Lindsey, R.W., “Permanent Post-Traumatic Patellar Dislocation, Journal of Trauma, 24(9) pp 1389-92, 1988

• Miller, M.D. “Retrospective Study of Pelvic Fractures at the Medical Center Hospital of Vermont,” unpublished study, 1987

• Markgraf, J.H., Bums, D.B., Greeno, E.W., Leonard, K.J., Miller, M.D., “The Dehydration of Allylic and Benzylic Cycloalkanoids by Molecular Sieves,” Synthetic Communications, 14(7), pp 647-653, 1984